Trial intelligence / Profile preview

Central Insulin and taVNS Effects on Metabolism

NCT01479075Phase 4Completed

Sponsor
German Diabetes Center
Start
Aug 2011
Primary completion
Jan 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of regular human insulin in type 2 diabetes mellitus (T2DM), sponsored by German Diabetes Center. Started Aug 2011; status: completed.

02

Drugs

regular human insulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01479075.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01479075.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call